Substituted 8-arylquinolune PDE4 inhibitors
US6919353B2 · kind B2 · utility
2Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2002 |
| Grant date | Jul 19, 2005 |
| Priority date | — |
| Expiry date | Jun 26, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/657181
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
8-arylquinolines of formula (I) wherein the aryl group at the 8-position contains a meta two atom bridge to an optionally substituted phenyl or pyridyl group, are PDE4 inhibitors useful to treat asthma, chronic bronchitis, chronic obstructive pulmonary disease, arthritis, respiratory distress syndrome, allergic rhinitis, neurogenic inflammation, pain, rheumatoid arthritis, and other diseases. R1-R7 and Ar are as in claim 1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.